Filing Details
- Accession Number:
- 0001077183-20-000227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-15 20:51:33
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-15 20:51:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1761625 | Martin Lawrence Weiss | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-14 | 50,000 | $6.98 | 61,717 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 20,000 | $7.27 | 81,717 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 13,333 | $9.22 | 95,050 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 16,666 | $13.87 | 111,716 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 9,005 | $19.60 | 120,721 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-14 | 20,200 | $51.06 | 100,521 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 50,000 | $0.00 | 50,000 | $6.98 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 20,000 | $0.00 | 20,000 | $7.27 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 13,333 | $0.00 | 13,333 | $9.22 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 16,666 | $0.00 | 16,666 | $13.87 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 9,005 | $0.00 | 9,005 | $19.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-03-01 | No | 4 | M | Direct | |
0 | 2022-05-25 | No | 4 | M | Direct | |
6,667 | 2023-04-19 | No | 4 | M | Direct | |
8,334 | 2023-12-12 | No | 4 | M | Direct | |
27,017 | 2024-03-01 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $28.33 | 2027-03-02 | 37,514 | 37,514 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-03-02 | 37,514 | 37,514 | Direct |
Footnotes
- On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.